Quotient Clinical, a business unit of Quotient Bioresearch ("Quotient"), will present two significant poster publications at the forthcoming American Society for Clinical Pharmacology and Therapeutics (ASCPT) meeting to be held on March 12th to 17th in Maryland, USA. 

Co-authored with scientists from seven leading pharmaceutical companies; AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer and Takeda, the first publication - Applications of exploratory clinical trials in drug development - review of exploratory trials user group meeting- reviews the proceedings of a user group meeting that discussed the impact of ICHM3 exploratory clinical trials guidance on conventional drug development paradigms. 

The second publication, co-authored with scientists from GlaxoSmithKline and entitled: A microtracer study of GSK962040, a motilin receptor agonist, to support dosing regimens in the critical care setting, describes the application of Quotient's ivMicrotracer^TM technology to support the development of an IV drug product for GSK962040 (a selective motilin agonist) for use in the critical care setting. 

Mark Egerton, Managing Director, Quotient Clinical commented: "These publications demonstrate our commitment to collaborating with our customers on innovative and high-quality clinical research. ICHM3 exploratory studies are being applied increasingly within drug development, with a clear goal of improving the processes by which new medicines are developed."

Details of the two publications are: 

Applications of exploratory clinical trials in drug development - review of exploratory trials user group meeting

Poster Session I (Abstract ID 347; Poster ID 12)

Date: Thursday 15^th March 2012, at 8.00am
  

A microtracer study of GSK962040, a motilin receptor agonist, to support dosing regimens in the critical care setting

Poster Session II (Abstract ID 445; Poster ID 75)

Date: Friday 16^th March 2012, at 8.00am
 

Quotient will be located at exhibition booth #234 at the conference, and senior members of the Quotient team will be attending the meeting. Copies of the posters will be made available at the booth or via download from the Quotient website at http://www.quotientbioresearch.com/publications/posters.